Media Summary: The SLE webcast reviews the process, potential benefits, and value of ... drug repurposing, aimed at small rare disease patient groups. To find out more about drug repurposing, ACS Science Talks features a series of lectures by many researchers in different diverse fields of chemistry from around the world.

Drug Repositioning - Detailed Analysis & Overview

The SLE webcast reviews the process, potential benefits, and value of ... drug repurposing, aimed at small rare disease patient groups. To find out more about drug repurposing, ACS Science Talks features a series of lectures by many researchers in different diverse fields of chemistry from around the world. Dr Bruce Bloom, president and dhief science officer of Cures WIthin Reach talks about this non-profit organization that is ... universityofnewcastle Professor Nikola Bowden, Co-director of HMRI's This video forms part of the AI3SD Seminar Series 2020. Professor John Overington from the

Findacure [charity number 1149646] organised its second scientific conference on the topic of '

Photo Gallery

Drug Repositioning
The Scientific Basis of Drug Repositioning in SLE
Intro to Drug Repurposing for Small Patient Groups
Webinar Replay - Drug Repositioning in Today's Challenging Times
Science Talks Lecture 26: Drug Repositioning
Introduction to Computational Drug Repositioning
From drug repositioning to target... - Satoko Namba - TransMed - Proceedings - ISMB 2022
Network Strategies for Drug Repurposing for Future Pandemics (Joe Loscalzo, Harvard Medical School)
Repurposing Old Drugs for New Indications
Drug repurposing: Finding new uses for existing treatments
AI3SD Summer Seminar Series 1 - Drug Repositioning for COVID-19 - Professor John Overington
Transcriptomics-based drug repositioning pipeline... - Brian Le - COVID-19 Special Track - ISMB 2020
View Detailed Profile
Drug Repositioning

Drug Repositioning

Computational

The Scientific Basis of Drug Repositioning in SLE

The Scientific Basis of Drug Repositioning in SLE

The SLE webcast reviews the process, potential benefits, and value of

Intro to Drug Repurposing for Small Patient Groups

Intro to Drug Repurposing for Small Patient Groups

... drug repurposing, aimed at small rare disease patient groups. To find out more about drug repurposing,

Webinar Replay - Drug Repositioning in Today's Challenging Times

Webinar Replay - Drug Repositioning in Today's Challenging Times

Drug

Science Talks Lecture 26: Drug Repositioning

Science Talks Lecture 26: Drug Repositioning

ACS Science Talks features a series of lectures by many researchers in different diverse fields of chemistry from around the world.

Introduction to Computational Drug Repositioning

Introduction to Computational Drug Repositioning

Computational

From drug repositioning to target... - Satoko Namba - TransMed - Proceedings - ISMB 2022

From drug repositioning to target... - Satoko Namba - TransMed - Proceedings - ISMB 2022

From

Network Strategies for Drug Repurposing for Future Pandemics (Joe Loscalzo, Harvard Medical School)

Network Strategies for Drug Repurposing for Future Pandemics (Joe Loscalzo, Harvard Medical School)

National Symposium on

Repurposing Old Drugs for New Indications

Repurposing Old Drugs for New Indications

Dr Bruce Bloom, president and dhief science officer of Cures WIthin Reach talks about this non-profit organization that is ...

Drug repurposing: Finding new uses for existing treatments

Drug repurposing: Finding new uses for existing treatments

universityofnewcastle Professor Nikola Bowden, Co-director of HMRI's

AI3SD Summer Seminar Series 1 - Drug Repositioning for COVID-19 - Professor John Overington

AI3SD Summer Seminar Series 1 - Drug Repositioning for COVID-19 - Professor John Overington

This video forms part of the AI3SD Seminar Series 2020. Professor John Overington from the

Transcriptomics-based drug repositioning pipeline... - Brian Le - COVID-19 Special Track - ISMB 2020

Transcriptomics-based drug repositioning pipeline... - Brian Le - COVID-19 Special Track - ISMB 2020

Transcriptomics-based

Drug Repositioning for Fundamental Diseases - Speaker 2

Drug Repositioning for Fundamental Diseases - Speaker 2

Findacure [charity number 1149646] organised its second scientific conference on the topic of '